武汉益承生物科技有限公司创始人，他领导完成创新药伊匹乌肽开发研究；伊匹乌肽治疗多种眼部疾病机理清晰，既能有效缓解炎症症状，减轻患者痛苦和不适，同时又能促进损伤愈合组织再生，恢复受损组织正常功能；同时，伊匹乌肽药物集有效和安全于一身，作用广泛，具有极大的临床价值。

 The founder of Wuhan Yicheng Biotechnology Co., he led the the development of the innovative drug Epivotide. The mechanism of Epivotide in treating various ocular diseases is well elucidated: it not only alleviates inflammatory symptoms and reduces patient discomfort but also promotes tissue regeneration in damaged areas, restoring normal function to affected tissues. In addition, Epivotide combines efficacy with low toxicity, exhibits broad therapeutic effects, and possesses significant clinical value.